000153 Stock Overview
Researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Anhui Fengyuan Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.13 |
| 52 Week High | CN¥6.97 |
| 52 Week Low | CN¥4.26 |
| Beta | 0.74 |
| 1 Month Change | -9.05% |
| 3 Month Change | 0.16% |
| 1 Year Change | -9.66% |
| 3 Year Change | -24.72% |
| 5 Year Change | 30.82% |
| Change since IPO | 0.64% |
Recent News & Updates
Shareholder Returns
| 000153 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -2.4% |
| 1Y | -9.7% | -7.7% | 6.6% |
Return vs Industry: 000153 underperformed the CN Pharmaceuticals industry which returned -7.7% over the past year.
Return vs Market: 000153 underperformed the CN Market which returned 6.6% over the past year.
Price Volatility
| 000153 volatility | |
|---|---|
| 000153 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 000153 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000153's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 4,670 | Tianle Ru | www.bbcayy.com |
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China. It offers products in various categories, which includes gynecology, respiratory system, hormonal, antipyretic analgesic, mental class, antiviral class, antibiotic class, oral anesthetic, masks class, urinary, water electrolyte balance, digestive system, cardiovascular class, Yinpian class, and nutrition and metabolism, as well as provides raw material drugs. The company also exports its products to Africa, Southeast Asia, Central Asia, Europe, and internationally.
Anhui Fengyuan Pharmaceutical Co., Ltd. Fundamentals Summary
| 000153 fundamental statistics | |
|---|---|
| Market cap | CN¥2.85b |
| Earnings (TTM) | CN¥164.12m |
| Revenue (TTM) | CN¥4.31b |
17.4x
P/E Ratio0.7x
P/S RatioIs 000153 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000153 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.31b |
| Cost of Revenue | CN¥3.33b |
| Gross Profit | CN¥978.84m |
| Other Expenses | CN¥814.72m |
| Earnings | CN¥164.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 22.70% |
| Net Profit Margin | 3.81% |
| Debt/Equity Ratio | 42.7% |
How did 000153 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/01 22:37 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Anhui Fengyuan Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Bin Liu | Guoyuan Securities Co., Ltd. |